aspira pathlab announced that M/s. Vishal J Bhanushali and Associates has resigned from the position of Internal Auditor with effect from August 13, 2026. The firm cited preoccupation and other personal reasons for the cessation of services. This disclosure impacts the company’s internal audit framework, requiring the Board to appoint a successor to ensure continued compliance with statutory audit requirements.

The resignation was communicated to the Bombay Stock Exchange (BSE) on August 03, 2026, by Nikunj Mange, Executive Director of Aspira Pathlab & Diagnostics Limited. The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Resignation Details

The key details of the auditor’s resignation are outlined below:

Vishal J. Bhanushali, Proprietor of M/s. Vishal J. Bhanushali & Associates (Firm Reg. No.: 145806W), submitted the resignation letter to the Board of Directors on August 03, 2026. In the letter, Bhanushali expressed gratitude for the opportunity and support extended by the Board and Management during his association with the company.

Regulatory Compliance

As per the regulatory framework, Aspira Pathlab & Diagnostics Limited is required to disclose such changes in its internal audit function promptly. The company has confirmed that there are no undisclosed relationships between the resigning auditor and the directors of the company. The Board is expected to take necessary steps to appoint a new Internal Auditor in accordance with applicable laws and regulations to maintain robust internal control mechanisms.

Aspira Pathlab & Diagnostics Limited has accepted the resignation of Pankaj Jashwant Shah as Managing Director and Chief Executive Director, effective immediately on August 3, 2026. The departure, cited as being due to personal reasons, marks a significant leadership change for the diagnostics firm, which must now navigate the transition without its top executive in place.

The company disclosed the development to BSE Limited pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made in compliance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Nikunj Mange, Executive Director of Aspira Pathlab, signed the exchange filing confirming the cessation of Mr. Shah’s tenure.

Resignation Details

Pankaj Jashwant Shah (DIN: 02836324) tendered his resignation from the office of Managing Director and Chief Executive Director. In his resignation letter addressed to the Board of Directors, Mr. Shah stated that he was stepping down due to personal reasons. The resignation becomes effective from the close of business hours on August 3, 2026.

Mr. Shah expressed gratitude to the Board and Management for the opportunity and support extended during his association with the company. He requested the Board to take necessary steps in connection with his resignation as required under applicable laws.

Leadership Transition

The Board of Directors has acknowledged the resignation. As per the disclosure, no relationships between directors were flagged as requiring additional disclosure in this context. The company is expected to inform shareholders about the appointment of a successor or interim arrangements in subsequent filings, though no such details were provided in this specific announcement.

What This Means for Stakeholders

The sudden departure of the Managing Director and Chief Executive Director creates an immediate leadership vacuum at Aspira Pathlab. Investors will be watching for clarity on interim management structures and the timeline for appointing a permanent successor. The absence of a detailed profile or forward-looking statement in the resignation letter suggests the transition may require urgent board-level action to ensure operational continuity.